论文部分内容阅读
答:目前化疗药物的疗效仍然较低,以胃癌为例,目前胃癌患者的单药化疗有效率仅为15%～30%,联合化疗的有效率仅为30%～50%。大家公认具有较高化疗疗效的乳腺癌新药,紫杉醇一线单药有效率为32%～62%,二线有效率仅为26%～33%。因此,探寻一种更科学高效的技术手段,在实施化疗之前,从体外检测肿瘤细胞的药物敏感性,是为患者“量身定制”治疗方案的关键。ATP-生物荧光体外抗肿瘤药物敏感性检测技术(ATP-
A: At present, the curative effect of chemotherapeutic drugs is still low. Taking gastric cancer as an example, the effective rate of single-agent chemotherapy in gastric cancer patients is only 15% -30%, and that of combined chemotherapy is only 30% -50%. We acknowledged that with high efficacy of chemotherapy, breast cancer drugs, paclitaxel first-line single drug effective rate was 32% to 62%, second-line efficiency of only 26% to 33%. Therefore, to explore a more scientific and efficient technical means to detect the drug sensitivity of tumor cells in vitro before chemotherapy is the key to the patient’s “tailor-made” treatment plan. ATP-bioluminescence in vitro antitumor drug sensitivity assay (ATP-